These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16756634)

  • 21. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
    Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
    J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Where are we with haemolytic uremic syndrome?
    Cavero T; Alonso M
    Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
    Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue.
    Atkinson JP; Liszewski MK; Richards A; Kavanagh D; Moulton EA
    Ann N Y Acad Sci; 2005 Nov; 1056():144-52. PubMed ID: 16387683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute renal failure and thrombotic microangiopathy (TM)].
    Imbasciati E; Bucci R; Barbisoni F; Borlandelli S; Corradi B; Cosci P; Farina M; Mandolfo S
    G Ital Nefrol; 2003; 20(3):285-97. PubMed ID: 12881852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemolytic uremic syndrome by Streptococcus pneumoniae].
    Herrero-Morín JD; Fernández N; Santos F; Rey C; Málaga S
    Nefrologia; 2007; 27(4):505-8. PubMed ID: 17944589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C; Goldstein J; Silberstein C; Zotta E; Belardo M; Repetto HA
    Arch Argent Pediatr; 2008 Oct; 106(5):435-42. PubMed ID: 19030644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
    Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
    Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Children on the frontline against E. coli": typical hemolytic-uremic syndrome.
    Andersen H
    Clin Lab Sci; 2005; 18(2):90-9. PubMed ID: 15916241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic uremic syndrome: pathogenesis and update of interventions.
    Palermo MS; Exeni RA; Fernández GC
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):697-707. PubMed ID: 19681698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Update on the treatment of endemic hemolytic uremic syndrome. Pathogenesis and treatment of the most severe systemic complication of infections by Shiga toxin-producing Escherichia coli].
    Fernández-Brando RJ; Bentancor LV; Mejías MP; Panek AC; Cabrera GG; Exeni RA; Palermo MS
    Medicina (B Aires); 2011; 71(4):383-9. PubMed ID: 21893458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical practice. Today's understanding of the haemolytic uraemic syndrome.
    Scheiring J; Rosales A; Zimmerhackl LB
    Eur J Pediatr; 2010 Jan; 169(1):7-13. PubMed ID: 19707787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa M; Grinyó JM; Praga M; Torra R; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2013 Jan; 33(1):27-45. PubMed ID: 23364625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemolytic uremic syndrome.
    Mele C; Remuzzi G; Noris M
    Semin Immunopathol; 2014 Jul; 36(4):399-420. PubMed ID: 24526222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The haemolytic-uraemic syndrome in childhood.
    van de Kar NC; Monnens LA
    Baillieres Clin Haematol; 1998 Jun; 11(2):497-507. PubMed ID: 10097822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Haemolytic uraemic syndrome in children--a systematic review].
    Bayat A; Kamperis K; Rittig S
    Ugeskr Laeger; 2012 May; 174(19):1302-7. PubMed ID: 22564687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].
    Frémeaux-Bacchi V
    Biol Aujourdhui; 2013; 207(4):231-40. PubMed ID: 24594571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased severity of Shiga toxin-producing
    Geramita MA; Hofer J; Cooper J; Moritz ML
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28855217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.